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Development of the human pancreas is well-known to involve tightly controlled differentiation of pancreatic
precursors to mature cells that express endocrine- or exocrine-speciﬁc protein products. However, details of human
pancreatic development at the ultrastructural level are limited. The present study analyzed 8–20 week fetal age human
pancreata using scanning and transmission electron microscopy (TEM), TEM immunogold and double or triple
immunoﬂuorescence staining. Primary organization of islets and acini occurred during the developmental period
examined. Differentiating endocrine and exocrine cells developed from the ductal tubules and subsequently formed
isolated small clusters. Extracellular matrix ﬁbers and proteins accumulated around newly differentiated cells during
their migration and cluster formation. Glycogen expression was robust in ductal cells of the pancreas from 8–15 weeks
of fetal age; however, this became markedly reduced at 20 weeks, with a concomitant increase in acinar cell glycogen
content. Insulin secretory granules transformed from being dense and round at 8 weeks to distinct geometric
(multilobular, crystalline) structures by 14–20 weeks. Initially many of the differentiating endocrine cells were
multihormonal and contained polyhormonal granules; by 20 weeks, monohormonal cells were in the majority.
Interestingly, certain secretory granules in the early human fetal pancreatic cells showed positivity for both exocrine
(amylase) and endocrine proteins. This combined ultrastructural and immunohistochemical study showed that, during
early developmental stages, the human pancreas contains differentiating epithelial cells that associate closely with the
extracellular matrix, have dynamic glycogen expression patterns and contain polyhormonal as well as mixed endocrine/
exocrine granules.

Introduction
The pancreas is a gastrointestinal-derived organ composed of
endocrine and exocrine compartments. Development of the
human pancreas begins on day 26 post-conception when the dorsal pancreatic bud evaginates followed by ventral bud formation
from the gut tube.1 Many factors are involved in these processes,
including interactions with the mesenchyme2 and expression of
pancreatic-specific transcription factors.3,4 Both buds then elongate and branch extensively, followed by gut tube rotation, bud
fusion and duct interconnection by the 6th or 7th week fetal
age.1,5 By 7.5 weeks, insulin-positive cells are detectable in the

fetal pancreas; glucagon and somatostatin are present by 8.5
weeks.1 Pancreatic polypeptide-expressing cells follow, with
expression at 10 weeks, in conjunction with an overall increase in
hormone-expressing cells.1
Up to »9 weeks of fetal life, a majority of the hormoneexpressing cells are isolated or in small aggregates located adjacent
to the ductal tree6 and often co-express cytokeratin 19 (CK19; a
marker of ductal cells), suggesting that ductal cells represent a
population of pancreatic progenitors.1,4,7 By 10–12 weeks, insulin-positive cells begin to cluster with glucagon-positive cells. By
13–15 weeks, these cells, along with other hormone-expressing
cells, aggregate into larger immature islet structures that are
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beginning to be invaded by blood vessels.1,4,7 The close association of endocrine cells with ducts has been observed not only during human pancreatic development8 but also in the adult human
pancreas.9 Pancreatic ducts, identified by carbonic anhydrase II,
were shown to be progenitors for developing islets.10
Ultrastructural analysis provides insight into cellular compartments, including organelles and secretory granules, along with
general cellular morphology. Transmission electron microscopy
analysis of human fetal pancreatic exocrine tissue has shown
increases in rough endoplasmic reticulum and zymogen granules
from 12 to 19 weeks fetal age.11 Similar investigations of the
human fetal endocrine compartment at 12–20 weeks fetal age
have identified, by immunohistochemistry, numerous epithelial
cells that not only contained multiple pancreatic endocrine hormones12,13 but also individual granules containing multiple hormones, as analyzed by electron microscopy.14,15 However, details
of human pancreatic development at the ultrastructural level are
limited. The objective of the present study was to analyze human
pancreatic ultrastructure from 8 to 20 weeks of fetal life using a
3-pronged approach: scanning and transmission electron microscopy (SEM and TEM), TEM immunogold staining and double
as well as triple immunofluorescence staining.

Materials and Methods
Human fetal pancreas collection
Human fetal pancreatic samples (8–20 weeks fetal age) were
collected according to protocols approved by the Health Sciences
Research Ethics Board at Western University, in line with the
Canadian Council on Health Sciences Research Involving
Human Subjects guidelines. Samples were dissected immediately
and processed for electron microscope, immunogold and immunofluorescence analyses.
Tissue processing for transmission electron microscopy
Fetal pancreata were fixed in 2.5% glutaraldehyde in 0.1 M
phosphate buffer and post-fixed with 1% osmium tetroxide.
After dehydration through a graded ethanol series and propylene
oxide treatment, samples were embedded in araldite medium and
cured at 65 C overnight. Semi-thin (500 nm) and ultra-thin
(60 nm) sections were prepared. Silver-gold ultra-thin sections
were stained with 2% uranyl acetate in ethanol and Reynolds’
lead citrate, then examined with a Philips 410 electron microscope (FEI, Hillsboro, OR, USA) at 60 kgvolts. Eight pancreata
collected from 8 to 20 weeks of fetal age were processed for TEM
analysis. Cells or clusters labeled as “Endo” are identified by the
presence of endocrine granule structures.
Tissue processing for scanning electron microscopy
Human fetal pancreas samples were cut into 2 £ 2 mm fragments, fixed with 2.5% glutaraldehyde at 4 C overnight and
then dehydrated with an increasing concentration gradient of
ethanol. Samples were subjected to critical point drying and palladium-gold coating, then visualization by a 3400-N Variable
Pressure Scanning Electron Microscope (Hitachi, Saskatoon, SK,
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Canada). Four pancreata collected from 9, 14, 16 and 20 weeks
of fetal age were processed for SEM analysis.
Immunogold labeling for transmission electron microscopy
Processed human fetal ultra-thin sections cut at a thickness
of 60 nm were adhered to formvar-carbon coated nickel grids
(Canemco-Marivac, Gore, QC, Canada). After blocking nonspecific binding sites, grids were treated with primary antibodies:
insulin (I2018, Sigma), glucagon (sc-13091, Santa Cruz),
somatostatin (18-0078), pancreatic polypeptide (18-0043,
Zymed) and amylase (171534, Calbiochem). Grids were then
incubated with a secondary antibody conjugated with either
10 nm or 20 nm gold particles (ab27241 and ab27237, Abcam)
and counterstained with 2% uranyl acetate in water. Staining was
reviewed with a Philips 410 electron microscope (FEI, Hillsboro,
OR, USA) at 60 kgvolts. Negative controls omitted the primary
or secondary antibodies.
Immunofluorescence and PAS staining
Human fetal pancreas samples were fixed in 4% paraformaldehyde and paraffin embedded. Sections (4 mm) were prepared and
stained with either appropriate dilutions of primary antibodies,
including CK19 (M0888, Dako), pancreatic and duodenal homeobox 1 (PDX-1; Dr. Wright, University of Vanderbilt), insulin (180067, Invitrogen, Camarillo, CA, USA), glucagon (G2654,
Sigma), somatostatin (ab30788, Abcam), pancreatic polypeptide
(18-0043, Zymed), amylase (171534, Calbiochem), collagen I
(ab6308, Abcam), collagen IV (MAB1910), laminin (AB19012)
and fibronectin (MAB1926, Millipore) or Schiff’s reagent for PAS
staining (24200-1, Polysciences Inc.).16 Slides were then treated
with either fluorescent secondary antibodies (obtained from Jackson Immunoresearch Laboratories) or haematoxylin as a counterstain, and at least 3 pancreata per age group were examined.

Results
Histological and ultrastructural changes in the 8–20 week
human fetal pancreas
Double immunofluorescence staining for insulin/glucagon in
the human fetal pancreas showed increased endocrine cell presence
and organization into islet-like structures as development occurred
(Fig. 1A). As well, multihormonal insulin/glucagon double positive
cells decreased as the pancreas aged. Staining for CK19/amylase
revealed a switch between high ductal presence/few acinar cells at 8
weeks, to fewer ducts/many acinar cells at 20 weeks (Fig. 1A). Initially, at 8 weeks, pancreatic epithelial cells were organized into ductal structures surrounded by scattered individual mesenchymal-like
stellate cells; multiple layers of the epithelial cells with few or no
granules suggest outgrowth from the ducts (Fig. 1B/C, left panels).
Also, at 8 weeks, CK19 and amylase co-localization was detected in
some of these cells (Fig. 1A, lower panel). By 14 weeks, epithelial
cells had formed small clusters separate from the ducts (Fig. 1B/C,
middle panels). From 14–20 weeks, acinar cells increased in number and formed amylaseC cell clusters with centroacinar cells
labeled by CK19 (Fig. 1A, middle and right panels). Other cell
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Figure 1. The developing
(8–20 week) human fetal
pancreas. (A) Double immunoﬂuorescence for glucagon
or CK19 (green) with insulin
or amylase (red) and DAPI
stained nuclei in blue. Arrows
indicate double positive
labeled cells and enlarged
images inserted, while C
labels red blood cells, scale
bar D 50 mm. Representative
images from at least 3 pancreata per age group are
shown. (B) Semithin, (C) transmission electron and (D) scanning electron micrographs of
human fetal pancreata. Representative images from 4–8
pancreata are shown. A D acinar cell; C D cell, Endo D
endocrine cells, L D lumen of
duct, asterisks D blood vessels, and the dashed line outline newly differentiated cells
emerging from the duct.
Scale bars for semithin and
scanning electron micrographs (SEM) D 50 mm,
transmission electron micrographs (TEM) D 10 mm.

clusters that stained positive for insulin and glucagon had increased in
numbers and formed
more
developmentally
islet-like structure that
contained capillaries from
14–20 weeks of age
(Fig. 1A/B/C, middle
and right panels).
SEM images demonstrated a significant
amount of extracellular
matrix (ECM) fibers and
small scattered cells at 9
weeks; by 14–20 weeks
there was a major increase
in the number of epithelial cell clusters with a complex intercalation
of the ECM (Fig. 1D). Higher magnification of the SEM images
showed a pronounced ECM presence around the cell clusters as
well as surrounding each cell (Fig. 2A/A1/A2, B). To confirm the
presence of ECM proteins, double immunofluorescence was performed: 4 ECM proteins (collagen I and IV, fibronectin and laminin) were ubiquitously expressed in the pancreas, especially within
endocrine cells and surrounding endocrine cell clusters (Fig. 2C).
Another interesting observation was of glycogen accumulation
in the human fetal pancreas (Fig. 3A/B). Glycogen-positivity,
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determined by PAS staining, was very strong in ductal cells until
15 weeks of fetal life with light staining in the newly formed
endocrine cell clusters (Fig. 3B/B1, left and 2nd panels), similar
to what has been previously reported.6 By 20 weeks, however,
glycogen expression in ductal cells was reduced, while pancreatic
exocrine cell clusters became increasingly more positive (Fig. 3B/
B1, 3rd panels). In the adult pancreas, the glycogen staining was
observed in the exocrine compartment with no staining in endocrine or ductal cells, in accordance with previous reports
(Fig. 3B/B1, right panels).6
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Figure 2. Extracellular matrix localization in the developing human fetal pancreas. (A) Scanning electron micrographs of a human fetal pancreatic
cluster at 16 weeks fetal age indicating a complex organization of extracellular matrix (ECM) on the cell surface. Highlighted areas are enlarged in (A1)
and (A2). Scale bars D 10 mm (A and A1) and 1 mm (A2). (B) Transmission electron micrograph of ECM-endocrine cell interactions in the human fetal pancreas (8 and 14 weeks fetal age). Endo D endocrine cells, scale bars D 1 mm. (C) Double immunoﬂuorescence staining of a 14 week fetal age pancreas for
insulin (red) with collagen I, collagen IV, ﬁbronectin or laminin (all green), and DAPI-stained nuclei in blue. Scale bar D 50 mm, asterisks D blood cells.
Representative images from 4–10 pancreata are shown.

Human insulin granules display distinct geometric
structures
At 8 weeks fetal age, newly developed b-cells contained only a
few insulin granules that were dense and round (Fig. 4A/B/B1,
left panels) and frequently co-expressed glucagon, as determined
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by double immunogold staining (Fig. 4C, left panel). From 14
to 20 weeks, many of the insulin granules developed a distinct
geometric (multilobular, crystalline) morphology, which represents mature insulin granules (Fig. 4, middle and right panels).
By 20 weeks, crystalline insulin granules were the predominant
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Figure 3. Glycogen expression in the developing human fetal pancreas. (A) Transmission electron micrographs of the 8 week human fetal pancreas
showed glycogen positivity in ductal cells. Scale bars D 1 mm. L D lumen, Mit D mitochondria, N D nuclei, RER D rough endoplasmic reticulum. (B) PAS
stain (pink) indicates glycogen, which is highly expressed in ducts between 12–15 weeks. By 20 weeks of fetal age, glycogen expression is reduced in
ductal cells and is expressed primarily in surrounding acinar cell clusters with no islet or ductal cell expression in the adult pancreas. Highlighted areas
are enlarged in B1. Scale bar D 50 mm. Representative PAS images from at least 3 pancreata per age group are shown. A D acinar; CA D centroacinar;
IC D endocrine cell cluster; L D lumen of duct; asterisks D blood vessels.

form observed while there was a marked decrease in the number
of polyhormonal granules in the b-cells (Fig. 4, right panels).
Other types of pancreatic endocrine granules, identified by
immunogold labeling, showed relatively round granule structures
(Figs. 5 and 6).
Polyhormonal granules and multihormonal cells as well as
intermediate endocrine/exocrine cells in the developing human
fetal pancreas
Polyhormonal granules and multihormonal endocrine cells
were frequently observed in 14–16 week human fetal pancreata
determined by double immunogold labeled TEM and triple
immunofluorescent staining (Figs. 5 and 6). Double immunogold labeling revealed that insulin granules often contained
either glucagon (Fig. 5A/A1, left panels) or somatostatin
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(Fig. 5B/B1, left panels), while glucagon and somatostatin granules contained insulin signals (Fig. 5A/A1, right panels; 5B/B1,
right panels). Multihormonal cells containing both insulin and
glucagon granules were also observed in endocrine cells of the
human fetal pancreas (Fig. 5C, left panel) while triple immunofluorescence staining identified numerous cells with weak insulin
expression that also had glucagon and somatostatin positivity
(Fig. 5D). In addition, somatostatin or pancreatic polypeptide
positive granules contained immunoreactivity for glucagon
(Fig. 6A/A1), which was confirmed by triple immunofluorescence (Fig. 6B).
Finally, we identified intermediate endocrine-exocrine cells in
a 14 week fetal pancreas using TEM double immunogold and
double immunostaining approaches: interestingly, some insulin
granules showed positive labeling for amylase, while immature
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Figures 4. Insulin granules in the developing human fetal pancreas. Transmission electron micrographs of b-cells (A), insulin granules in b-cells
(B) with highlighted areas enlarged in (B1); and double immunogold staining for insulin (10 nm, arrows) and glucagon (20 nm, arrowheads) (C) in 8, 14
and 20 week human fetal pancreata. Representative images from 8 pancreata are shown. L D lumen, N D nuclei. Scale bars D 1 mm (A, B) and 100 nm
(B1, C). Arrows in A indicate insulin granules.

zymogen granules also contained insulin-positive signals
(Fig. 7A/A1). It was more common to observe amylase-positivity
in insulin granules rather than insulin-positivity in zymogen
granules (Fig. 7A/A1). These latter granules were rare, and as the
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pancreas aged, all cells with these characteristics were less prevalent. Further evidence for this phenomena was observed with
double immunostaining, in which some insulin and glucagon
positive cells colocalized with amylase (Fig. 7B).
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Figure 5. Polyhormonal granules and multihormonal cells in the developing human fetal pancreas. Transmission electron micrographs of double
immunogold staining for insulin and glucagon (A) or insulin and somatostatin (B) with highlighted areas enlarged in (A1) and (B1) in a 14 week human
fetal pancreas. A multihormonal (insulin and glucagon) cell (C, left panel) and 2 monohormonal (glucagon above, insulin below) cells (C, right panel) are
also shown. Secondary gold antibodies for insulin (10 nm, arrows), glucagon and somatostatin (20 nm, arrowheads). Scale bars D 250 nm. (D) Triple
immunoﬂuorescence staining of glucagon (blue), somatostatin (green) and insulin (red), indicating that speciﬁc cells are positive for all 3 hormones
(arrows) in the human fetal pancreas at 16 weeks fetal age. Highlighted areas are enlarged in the top and bottom insets, scale bar D 50 mm. G D glucagon granules, I D insulin granules, M D plasma membranes, N D nucleus, S D somatostatin. Representative images from 8–10 pancreata are shown.

Discussion
In the present study, we observed that, during the early stages
of its development, the human pancreas consisted primarily of a
ductal tree, ECM proteins/fibers and a few cell clusters bordering
the ducts. As development continued, the cell clusters became
separate from the ductal tree and intercalated with the ECM,
eventually forming the endocrine islets and exocrine acini of a
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more mature pancreas by 20 weeks fetal age. Glycogen was
strongly expressed in 8 and 15 week pancreatic ductal cells and
lightly in newly formed endocrine cell clusters, but this expression shifted to acinar cell clusters by 20 weeks. Insulin granule
maturation was associated with the appearance of multi-lobed
geometric structures by 14 weeks. The developing human
pancreas also initially contained cells expressing multiple hormones; the majority of these cells became monohormonal by
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Figure 6. Glucagon signals present in somatostatin and pancreatic polypeptide granules. Double immunogold staining reveals glucagon (10 nm,
arrows) and somatostatin (20 nm, arrowheads) (A, left panel) or pancreatic polypeptide (20 nm, arrowheads) (A, right panel) positivity in a single endocrine cell granule in a 14 week human fetal pancreas. Highlighted areas are enlarged in (A1). Scale bar D 250 nm. (B) Triple immunoﬂuorescence staining
of pancreatic polypeptide (blue), somatostatin (green) and glucagon (red) reveals speciﬁc cells positive for multiple hormones (arrows) in the 14 weeks
fetal pancreas. Highlighted area is enlarged in far right panel, scale bar D 50 mm. N D nucleus, PP D pancreatic polypeptide granules, S D somatostatin
granules. Representative images from 8–10 pancreata are shown.

mid-gestation. Of particular interest was the finding of insulin or
glucagon and amylase expressed within the same cells, indicating
that the intermediate endocrine-exocrine cells, described in nonhuman species, are also present in the human fetal pancreas.17-19
Our ultrastructural analysis of human fetal insulin granules
demonstrated spherical monolobed structures at 8 weeks fetal age
which turned into multi-lobed geometric crystal granules by 20
weeks. Mature insulin granule structures differ significantly
between rodents and humans.20 The unique crystalline structure
of mature human insulin granules has implications for human
embryonic stem cell (hESC)-derived insulin-producing cells:
their insulin granules more closely resemble mature mouse
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insulin granules21 or the immature human fetal insulin forms,
suggesting that problems associated with hESC-derived b-cell
development may involve unsatisfactory insulin granule
maturation.
In the present study, cells containing polyhormonal granules
or multiple monohormonal granules were often observed in the
8–16 week human fetal pancreas. In each case where there were
polyhormonal granules, the granule had a primary hormone that
had very strong positive staining, with a lower expression level of
a secondary hormone. These data indicate that setting up cellular
machinery is a primary goal for early pancreatic cells, rather than
lineage determination. Our findings are supported by 2 previous
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Figure 7. Co-expression of amylase with insulin in the human fetal pancreas. (A) Double immunogold staining of insulin (10 nm, arrows) and amylase (20 nm, arrowheads) in the human fetal pancreas at 14 weeks fetal age, with highlighted areas enlarged in A1. Scale bars D 250 nm. (B) Double
immunoﬂuorescence stain of amylase (green) with either insulin (red) [upper row] or glucagon [lower row] in the human fetal pancreas at 14 weeks of
fetal age. Highlighted areas are enlarged in the far right panels: they suggest co-expression of amylase with insulin and glucagon (arrows). Scale
bar D 50 mm. Am D amylase, I D insulin, N D nucleus. Representative images from 8–10 pancreata are shown.
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immunogold studies of the human fetal pancreas, which demonstrated that individual cells had polyhormonal granules containing various combinations of insulin, glucagon, somatostatin and
pancreatic polypeptide.12,14 The fact that the polyhormonal cells
are less frequent at 20 weeks indicates an ongoing maturation
process within the endocrine pancreas.
The current study supports the idea of a common progenitor
cell for both the endocrine and exocrine pancreas by demonstrating, for the first time in the human, co-expression of endocrine
hormones (insulin and glucagon) with an exocrine enzyme (amylase). Intermediate cells that express insulin and amylase in separate granules have been identified in the pancreas of adult rats
that have undergone pancreatic duct ligation,17 and in the normal pancreas of the adult rat, guinea-pig, monkey, goat, chicken
and frog, where the cells contain immature zymogen granules
along with insulin, glucagon or somatostatin hormone-containing granules.18,19 These intermediate cells are described as changing from one differentiated cell state to another in response to
demands of the organism, but this process is not well understood.
The present ultrastructural and immunohistochemical analysis of human fetal pancreatic development from early to
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